Piper Sandler Reaffirms Their Hold Rating on Quest Diagnostics (DGX)
In a report released today, David Westenberg from Piper Sandler reiterated a Hold rating on Quest Diagnostics (DGX – Research Report), with a ...
Blue Trust Inc. Purchases 390 Shares of Quest Diagnostics Incorporated (NYSE:DGX)
Blue Trust Inc. lifted its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 28.0% during the 4th ...
Earnings call transcript: Quest Diagnostics Q4 2024 beats EPS forecast
Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...
Quest beats quarterly estimates on strong diagnostic test demand
Laboratory operator Quest Diagnostics beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by a robust appetite for its diagnostic tests.